---
title: 'Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications'
date: '2023-08-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37586177/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230817180900&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Approximately 1-2% of advanced NSCLC harbor rare fusions,
  which are potentially actionable and may support diagnosis. Routine adoption of
  broad NGS assays capable to identify exact fusion points and potentially retained
  protein domains can increase the yield of therapeutically relevant molecular information
  in advanced ...'
disable_comments: true
---
CONCLUSION: Approximately 1-2% of advanced NSCLC harbor rare fusions, which are potentially actionable and may support diagnosis. Routine adoption of broad NGS assays capable to identify exact fusion points and potentially retained protein domains can increase the yield of therapeutically relevant molecular information in advanced ...